Shattuck Labs (STTK) Net Cash Flow (2019 - 2026)
Shattuck Labs (STTK) reported Net Cash Flow of $36.2 million for Q1 2026, up 931.81% year-over-year from $3.5 million in Q1 2025, and up 211.12% quarter-over-quarter from $11.6 million in Q4 2025.
Shattuck Labs (STTK) Net Cash Flow (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Net Cash Flow data on file, last reported at $36.2 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $36.2 million, up 931.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.5 million (up 295.41% YoY), and the FY2025 annual result was -$3.2 million, up 95.32% from the prior year.
- Net Cash Flow advanced to $36.2 million in Q1 2026 per STTK's latest filing, from $11.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $85.0 million in Q4 2023 and troughed at -$49.6 million in Q1 2024.
- A 5-year average of -$108764.7 and a median of $1.9 million in 2022 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 1015.26% in 2023 and fell as far as 1755.77% in 2023.
- A 5-year view of Net Cash Flow shows it stood at $7.6 million in 2022, then soared by 1015.26% to $85.0 million in 2023, then slumped by 84.05% to $13.6 million in 2024, then decreased by 14.12% to $11.6 million in 2025, then jumped by 211.12% to $36.2 million in 2026.
- Business Quant data shows STTK's Net Cash Flow at $36.2 million in Q1 2026, $11.6 million in Q4 2025, and -$7.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 36.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.23 Mn |
| Mar 31, 2026 | 36.23 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 13.56 Mn |
| Dec 31, 2024 | 13.56 Mn |
| Sep 30, 2024 | -16.86 Mn |
| Sep 30, 2024 | -16.86 Mn |
| Jun 30, 2024 | -15.31 Mn |
| Jun 30, 2024 | -15.31 Mn |
| Mar 31, 2024 | -49.62 Mn |
| Mar 31, 2024 | -49.62 Mn |
| Dec 31, 2023 | 84.99 Mn |
| Dec 31, 2023 | 84.99 Mn |